Related Experiment Video
Updated: May 10, 2025

09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.3K
Engineering bioactive mineralized tumor cells for tumor immunotherapy
Zikun Shen1, Yan He1, Ren Mo2
1School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Frontiers in Bioengineering and Biotechnology
|April 28, 2025
Summary
Engineered whole-cell tumor vaccines using mineralized tumor cells and CpG show significant tumor suppression. This novel immunotherapy approach enhances immune cell activity and extends survival in preclinical models.
Area of Science:
- Immunology
- Biotechnology
- Cancer Research
Background:
- Whole-cell tumor vaccines offer broad immune responses by presenting diverse tumor antigens.
- Current whole-cell vaccines can be enhanced for greater therapeutic efficacy.
Purpose of the Study:
- To develop and evaluate a multifunctional whole-cell tumor vaccine.
- To investigate the immune-activating properties of manganese-mineralized tumor cells combined with CpG.
Main Methods:
- Engineered a vaccine using manganese-mineralized B16F10 tumor cells with immobilized CpG.
- Assessed dendritic cell maturation via cGAS-STING and TLR9 pathway activation.
- Evaluated tumor suppression and survival in B16F10 tumor-bearing mice.
Main Results:
- The engineered vaccine significantly reduced tumor volume (to ~1/5th) and extended survival to day 30 in mice.
- Observed enhanced dendritic cell activation, increased NK and CD8+ T cell infiltration.
- Detected increased immune cytokine production within the tumor microenvironment.
Conclusions:
- Bioactive mineralized tumor cells represent a promising strategy for whole-cell tumor vaccine immunotherapy.
- This approach effectively leverages the immune system to combat cancer growth.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K

